This cross-sectional study found that the prevalence of SARS-CoV-2 in the asymptomatic adult population of the Indianapolis metropolitan area was 3.1% Study called asymptomatic novel CORonavirus iNfection (ACORN), led by Eli Lilly researchers between April 7, 2020 and May 16,Read More
The cohort study modeled data from 50 different cities and found that SARS-CoV-2 appears to behave like a seasonal respiratory virus. 8 cities w/ substantial spread of COVID-19 were compared with 42 cities that have not been affected or didRead More
This case series reviewed the cardiac MRIs of 4 children and adolescents with multisystem inflammatory syndrome in children (MIS-C), with findings favoring post-infectious myocarditis without signs of coronary abnormalities. Study took place in France All 4 children underwent transthoracic echocardiographyRead More
A retraction notice was published regarding the study titled: “Cardiovascular disease, drug therapy, and mortality in COVID-19,” which appeared in The New England Journal of Medicine on May 1st. Because of concerns that arose from a separate study concerning dataRead More
A retraction notice was published regarding the study titled: “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,” which appeared in The Lancet on May 22nd. Concerns about the data were raised andRead More
This randomized trial showed that hydroxychloroquine did not prevent presumed/confirmed COVID-19 when used as post-exposure prophylaxis within 4 days of high- or moderate-risk COVID-19 exposure. This randomized, double-blind, placebo-controlled trial occurred across the United States and parts of Canada EnrolledRead More
This randomized clinical trial showed that convalescent plasma therapy + standard treatment did not improve time to clinic improvement within 28 days compared to standard treatment alone in patients with severe or life-threatening COVID-19. Patients were recruited from 7 medicalRead More
This study found that during the COVID-19 pandemic, patients presenting for ST-elevation myocardial infarction (STEMI) were more likely to present late and have lower left ventricle ejection fraction (LVEF) on presentation. From January 1, 2020, to April 15, 2020, 143Read More
This modeling study explored different interventions (not involving medications/vaccines) influencing new cases and deaths related to COVID-19 and found that intermittent periods of more intensive lockdown-type measures may be necessary to prevent healthcare systems from being overwhelmed. The model exploredRead More
This observational study found that half of the patient with negative IgM and RT-qPCR-positive SARS-CoV-2 had severe COVID-19 disease. IgM-based gold immunochromatographic assay (GICA) is the test used within this study, to investigate its utility Severe cases were defined asRead More